<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN""http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html><head><title>Patent US6514520 - Containing about 0.05 to about 5 mg/mL of an aminopolycarboxylic acid ... - Google Patents</title><script>(function(){(function(){function e(a){this.t={};this.tick=function(a,c,b){var d=void 0!=b?b:(new Date).getTime();this.t[a]=[d,c];if(void 0==b)try{window.console.timeStamp("CSI/"+a)}catch(e){}};this.tick("start",null,a)}var a;window.performance&&(a=window.performance.timing);var f=a?new e(a.responseStart):new e;window.jstiming={Timer:e,load:f};if(a){var c=a.navigationStart,d=a.responseStart;0<c&&d>=c&&(window.jstiming.srt=d-c)}if(a){var b=window.jstiming.load;0<c&&d>=c&&(b.tick("_wtsrt",void 0,c),b.tick("wtsrt_",
"_wtsrt",d),b.tick("tbsd_","wtsrt_"))}try{a=null,window.chrome&&window.chrome.csi&&(a=Math.floor(window.chrome.csi().pageT),b&&0<c&&(b.tick("_tbnd",void 0,window.chrome.csi().startE),b.tick("tbnd_","_tbnd",c))),null==a&&window.gtbExternal&&(a=window.gtbExternal.pageT()),null==a&&window.external&&(a=window.external.pageT,b&&0<c&&(b.tick("_tbnd",void 0,window.external.startE),b.tick("tbnd_","_tbnd",c))),a&&(window.jstiming.pt=a)}catch(g){}})();})();
</script><link rel="stylesheet" href="/patents/css/_8a2b04e7bf975d5171d8e4c0b6365c7a/kl_intl_patents_bundle.css" type="text/css" /><script src="/books/javascript/atb_8a2b04e7bf975d5171d8e4c0b6365c7a__en.js"></script><script>function googleTranslateElementInit() {new google.translate.TranslateElement({pageLanguage: "en",gaTrack: true,gaId: "UA-27188110-1",multilanguagePage: true});}</script><script src="//translate.google.com/translate_a/element.js?cb=googleTranslateElementInit"></script><meta name="DC.type" content="Patent"><meta name="DC.title" content="Containing about 0.05 to about 5 mg/mL of an aminopolycarboxylic acid, including salts such as disodium EDTA; especially the antihistamines loratadine, descarboethoxyloratadine, and azatadine"><meta name="DC.contributor" content="Farah J. Munayyer" scheme="inventor"><meta name="DC.contributor" content="Frank Guazzo" scheme="inventor"><meta name="DC.contributor" content="Elliot I. Stupak" scheme="inventor"><meta name="DC.contributor" content="Imtiaz A. Chaudry" scheme="inventor"><meta name="DC.contributor" content="Joel A. Sequeira" scheme="inventor"><meta name="DC.contributor" content="Schering Corporation" scheme="assignee"><meta name="DC.date" content="2001-7-5" scheme="dateSubmitted"><meta name="DC.description" content="An antihistaminic syrup is stabilized against degradation of the active ingredient, by the addition of and about 0.05 to about 5 mg/mL of an aminopolycarboxylic acid such as a salt of ethylenediaminetetraacetic acid."><meta name="DC.date" content="2003-2-4" scheme="issued"><meta name="DC.relation" content="EP:0620001:A1" scheme="references"><meta name="DC.relation" content="US:4659716" scheme="references"><meta name="DC.relation" content="US:4783465" scheme="references"><meta name="DC.relation" content="US:4975426" scheme="references"><meta name="DC.relation" content="US:5759579" scheme="references"><meta name="DC.relation" content="US:5912007" scheme="references"><meta name="DC.relation" content="US:5939426" scheme="references"><meta name="DC.relation" content="US:6132758" scheme="references"><meta name="DC.relation" content="WO:1998018470:A1" scheme="references"><meta name="DC.relation" content="WO:1998024414:A1" scheme="references"><meta name="citation_reference" content="Drug Facts and Comparisons, 1998 Ed., Facts and Comparisons, St. Louis, Missouri, p. 2832."><meta name="citation_reference" content="Remington&#39;s Pharmaceutical Sciences, 18th Ed., Mack Publishing Company, Easton, Pennsylvania, 1990, pp. 1519-1520 and 1527-1529."><meta name="citation_reference" content="The United States Pharmacopeia, The United States Formulary, United States Pharmacopeial Convention, Inc., Rockville, Maryland, 1989, p. 1990."><meta name="citation_patent_number" content="US:6514520"><meta name="citation_patent_application_number" content="US:09/899,764"><link rel="canonical" href="http://www.google.com/patents/US6514520"/><meta property="og:url" content="http://www.google.com/patents/US6514520"/><meta name="title" content="Patent US6514520 - Containing about 0.05 to about 5 mg/mL of an aminopolycarboxylic acid, including salts such as disodium EDTA; especially the antihistamines loratadine, descarboethoxyloratadine, and azatadine"/><meta name="description" content="An antihistaminic syrup is stabilized against degradation of the active ingredient, by the addition of and about 0.05 to about 5 mg/mL of an aminopolycarboxylic acid such as a salt of ethylenediaminetetraacetic acid."/><meta property="og:title" content="Patent US6514520 - Containing about 0.05 to about 5 mg/mL of an aminopolycarboxylic acid, including salts such as disodium EDTA; especially the antihistamines loratadine, descarboethoxyloratadine, and azatadine"/><meta property="og:type" content="book"/><meta property="og:site_name" content="Google Books"/><meta property="og:image" content="http://www.google.com/patents?id=&amp;printsec=frontcover&amp;img=1&amp;zoom=1"/><link rel="image_src" href="http://www.google.com/patents?id=&amp;printsec=frontcover&amp;img=1&amp;zoom=1"/><script>(function(){try{var aa=function(a,b,c,d){d=d||{};d._sn=["cfg",b,c].join(".");window.gbar.logger.ml(a,d)};var g=window.gbar=window.gbar||{},l=window.gbar.i=window.gbar.i||{},m={},n;function _tvn(a,b){var c=parseInt(a,10);return isNaN(c)?b:c}function _tvf(a,b){var c=parseFloat(a);return isNaN(c)?b:c}function _tvv(a){return!!a}function p(a,b,c){(c||g)[a]=b}g.bv={n:_tvn("2",0),r:"",f:".67.",e:"0",m:_tvn("0",1)};
function q(a,b,c){var d="on"+b;if(a.addEventListener)a.addEventListener(b,c,!1);else if(a.attachEvent)a.attachEvent(d,c);else{var f=a[d];a[d]=function(){var a=f.apply(this,arguments),b=c.apply(this,arguments);return void 0==a?b:void 0==b?a:b&&a}}}var s=function(a){return function(){return g.bv.m==a}},ba=s(1),ca=s(2);p("sb",ba);p("kn",ca);l.a=_tvv;l.b=_tvf;l.c=_tvn;l.i=aa;var da=window.gbar.i.i;var t,u,v,w;function ea(a){v=a}function fa(a){var b;if(b=v&&window.encodeURIComponent)b=a.href,b=!b.match(/^http[s]?:\/\/accounts\.google\.[^/]*\/ClearSID/i)&&!b.match(/^http[s]?:\/\/[^/]*\/accounts\/ClearSID/i);if(b=b&&encodeURIComponent(v()))a.href=a.href.replace(/([?&]continue=)[^&]*/,"$1"+b)}function ga(a){window.gApplication&&(a.href=window.gApplication.getTabUrl(a.href))}
function ha(a){var b=document.forms[0].q,c=window.encodeURIComponent&&b&&b.value,b=b&&b.placeholder;c&&c!=b&&(a.href=a.href.replace(/([?&])q=[^&]*|$/,function(a,b){return(b||"&")+"q="+encodeURIComponent(c)}))}n=l.a("")?ga:ha;
function x(a,b,c,d,f,e){var h=document.getElementById(a);if(h){var k=h.style;k.left=d?"auto":b+"px";k.right=d?b+"px":"auto";k.top=c+"px";k.visibility=u?"hidden":"visible";f&&e?(k.width=f+"px",k.height=e+"px"):(x(t,b,c,d,h.offsetWidth,h.offsetHeight),u=u?"":a)}}
var y=[],ia=function(a,b){y.push(b)},ja=function(a){a=a||window.event;var b=a.target||a.srcElement;a.cancelBubble=!0;null==t&&(a=document.createElement(Array.every||window.createPopup?"iframe":"div"),a.frameBorder="0",t=a.id="gbs",a.src="javascript:''",b.parentNode.appendChild(a),q(document,"click",z));var c=b,b=0;"gb3"!=c.className&&(c=c.parentNode);a=c.getAttribute("aria-owns")||"gbi";var d=c.offsetWidth,f=20<c.offsetTop?46:24;document.getElementById("tphdr")&&(f-=3);var e=!1;do b+=c.offsetLeft||
0;while(c=c.offsetParent);var c=(document.documentElement.clientWidth||document.body.clientWidth)-b-d,h,d=document.body,k=document.defaultView;k&&k.getComputedStyle?(d=k.getComputedStyle(d,""))&&(h=d.direction):h=d.currentStyle?d.currentStyle.direction:d.style.direction;h="rtl"==h;if("gbi"==a){for(d=0;k=y[d++];)k();A(null,window.navExtra);h&&(b=c,e=!0)}else h||(b=c,e=!0);u!=a&&z();x(a,b,f,e)},z=function(){u&&x(u,0,0)},A=function(a,b){var c,d=document.getElementById("gbi"),f=a;f||(f=d.firstChild);
for(;b&&(c=b.pop());){var e=d,h=c,k=f;w||(w="gb2");e.insertBefore(h,k).className=w}},ka=function(a,b,c){if((b=document.getElementById(b))&&a){a.className="gb4";var d=document.createElement("span");d.appendChild(a);d.appendChild(document.createTextNode(" | "));d.id=c;b.appendChild(d)}},la=function(){return document.getElementById("gb_70")},ma=function(){return!!u};p("qs",n);p("setContinueCb",ea);p("pc",fa);p("tg",ja);p("close",z);p("addLink",ka);p("almm",A);p("si",la);p("adh",ia);p("op",ma);var B=function(){},C=function(){},F=function(a){var b=new Image,c=D;b.onerror=b.onload=b.onabort=function(){try{delete E[c]}catch(a){}};E[c]=b;b.src=a;D=c+1},E=[],D=0;p("logger",{il:C,ml:B,log:F});var G=window.gbar.logger;var H={},na={},I=[],oa=l.b("0.1",.1),pa=l.a("1",!0),qa=function(a,b){I.push([a,b])},ra=function(a,b){H[a]=b},sa=function(a){return a in H},J={},K=function(a,b){J[a]||(J[a]=[]);J[a].push(b)},ta=function(a){K("m",a)},L=function(a,b){var c=document.createElement("script");c.src=a;c.async=pa;Math.random()<oa&&(c.onerror=function(){c.onerror=null;B(Error("Bundle load failed: name="+(b||"UNK")+" url="+a))});(document.getElementById("xjsc")||document.getElementsByTagName("body")[0]||
document.getElementsByTagName("head")[0]).appendChild(c)},N=function(a){for(var b=0,c;(c=I[b])&&c[0]!=a;++b);!c||c[1].l||c[1].s||(c[1].s=!0,M(2,a),c[1].url&&L(c[1].url,a),c[1].libs&&m.d&&m.d(c[1].libs))},O=function(a){K("gc",a)},P=null,ua=function(a){P=a},M=function(a,b,c){if(P){a={t:a,b:b};if(c)for(var d in c)a[d]=c[d];try{P(a)}catch(f){}}};p("mdc",H);p("mdi",na);p("bnc",I);p("qGC",O);p("qm",ta);p("qd",J);p("lb",N);p("mcf",ra);p("bcf",qa);p("aq",K);p("mdd","");p("has",sa);
p("trh",ua);p("tev",M);var Q=l.b("0.1",.001),R=0;
function _mlToken(a,b){try{if(1>R){R++;var c,d=a,f=b||{},e=encodeURIComponent,h=["//www.google.com/gen_204?atyp=i&zx=",(new Date).getTime(),"&jexpid=",e("17483"),"&srcpg=",e("prop=22"),"&jsr=",Math.round(1/Q),"&ogev=",e("fijuU-b8Cc6_sQSE0oC4Dg"),"&ogf=",g.bv.f,"&ogrp=",e("1"),"&ogv=",e("1407723702.0"),"&oggv="+e("es_plusone_gc_20140723.0_p0"),"&ogd=",e("com"),"&ogc=",e("PRT"),"&ogl=",e("en")];f._sn&&(f._sn="og."+
f._sn);for(var k in f)h.push("&"),h.push(e(k)),h.push("="),h.push(e(f[k]));h.push("&emsg=");h.push(e(d.name+":"+d.message));var r=h.join("");S(r)&&(r=r.substr(0,2E3));c=r;var Aa=window.gbar.logger._aem(a,c);F(Aa)}}catch(Na){}}var S=function(a){return 2E3<=a.length},va=function(a,b){return b};function T(a){B=a;p("_itl",S,G);p("_aem",va,G);p("ml",B,G);a={};H.er=a}l.a("")?T(function(a){throw a;}):l.a("1")&&Math.random()<Q&&T(_mlToken);I.push(["m",{url:"//ssl.gstatic.com/gb/js/scm_7385cc5883250b43a39405734c1bea59.js"}]);g.mcf("c",{});g.sg={c:""};if(l.a("1")){var wa=l.a("");I.push(["gc",{auto:wa,url:"//ssl.gstatic.com/gb/js/abc/gci_91f30755d6a6b787dcc2a4062e6e9824.js",libs:"googleapis.client:plusone:gapi.iframes"}]);var xa={version:"gci_91f30755d6a6b787dcc2a4062e6e9824.js",index:"",lang:"en"};H.gc=xa;var U=function(a){window.googleapis&&window.iframes?a&&a():(a&&O(a),N("gc"))};p("lGC",U);l.a("1")&&p("lPWF",U)};window.__PVT="";if(l.a("1")&&l.a("1")){var V=function(a){U(function(){K("pw",a);N("pw")})};p("lPW",V);I.push(["pw",{url:"//ssl.gstatic.com/gb/js/abc/pwm_45f73e4df07a0e388b0fa1f3d30e7280.js"}]);var W=[],ya=function(a){W[0]=a},za=function(a,b){var c=b||{};c._sn="pw";B(a,c)},Ba={signed:W,elog:za,base:"https://plusone.google.com/u/0",loadTime:(new Date).getTime()};H.pw=Ba;var X=function(a,b){for(var c=b.split("."),d=function(){var b=arguments;a(function(){for(var a=g,d=0,e=c.length-1;d<e;++d)a=a[c[d]];a[c[d]].apply(a,b)})},f=g,e=0,h=c.length-1;e<h;++e)f=
f[c[e]]=f[c[e]]||{};return f[c[e]]=d};X(V,"pw.clk");X(V,"pw.hvr");p("su",ya,g.pw)};function Ca(){function a(){for(var b;(b=e[h++])&&"m"!=b[0]&&!b[1].auto;);b&&(M(2,b[0]),b[1].url&&L(b[1].url,b[0]),b[1].libs&&m.d&&m.d(b[1].libs));h<e.length&&setTimeout(a,0)}function b(){0<f--?setTimeout(b,0):a()}var c=l.a("1"),d=l.a(""),f=3,e=I,h=0,k=window.gbarOnReady;if(k)try{k()}catch(r){da(r,"ml","or")}d?p("ldb",a):c?q(window,"load",b):b()}p("rdl",Ca);var Da={D:1,H:2,da:3,p:4,W:5,M:6,F:7,g:8,ha:9,U:10,L:11,T:12,S:13,N:14,Q:15,P:16,fa:17,w:18,O:19,ga:20,ea:21,u:22,G:23,ja:24,ka:25,ia:26,A:27,j:28,o:29,k:30,ca:31,Z:32,$:33,J:34,K:35,ba:36,aa:37,Y:38,B:39,R:40,v:41,X:42,V:43,h:48,C:49,I:500},Y=[1,2,3,4,5,6,9,10,11,13,14,28,29,30,34,35,37,38,39,40,41,42,43,48,49,500];var Z=l.b("0.001",1E-4),Ea=l.b("1",1),Fa=!1,Ga=!1;if(l.a("1")){var Ha=Math.random();Ha<=Z&&(Fa=!0);Ha<=Ea&&(Ga=!0)}var Ia=Da,$=null;function Ja(){var a=0,b=function(b,d){l.a(d)&&(a|=b)};b(1,"");b(2,"");b(4,"");b(8,"");return a}
function Ka(a,b){var c=Z,d=Fa,f;f=a;if(!$){$={};for(var e=0;e<Y.length;e++){var h=Y[e];$[h]=!0}}if(f=!!$[f])c=Ea,d=Ga;if(d){d=encodeURIComponent;g.rp?(f=g.rp(),f="-1"!=f?f:"1"):f="1";c=["//www.google.com/gen_204?atyp=i&zx=",(new Date).getTime(),"&oge=",a,"&ogex=",d("17483"),"&ogev=",d("fijuU-b8Cc6_sQSE0oC4Dg"),"&ogf=",g.bv.f,"&ogp=",d("22"),"&ogrp=",d(f),"&ogsr=",Math.round(1/c),"&ogv=",d("1407723702.0"),"&oggv="+
d("es_plusone_gc_20140723.0_p0"),"&ogd=",d("com"),"&ogl=",d("en"),"&ogc=",d("PRT"),"&ogus=",Ja()];if(b){"ogw"in b&&(c.push("&ogw="+b.ogw),delete b.ogw);var k;f=b;e=[];for(k in f)0!=e.length&&e.push(","),e.push(La(k)),e.push("."),e.push(La(f[k]));k=e.join("");""!=k&&(c.push("&ogad="),c.push(d(k)))}F(c.join(""))}}function La(a){"number"==typeof a&&(a+="");return"string"==typeof a?a.replace(".","%2E").replace(",","%2C"):a}C=Ka;p("il",C,G);var Ma={};H.il=Ma;setTimeout(function(){C(Ia.g)},0);}catch(e){window.gbar&&gbar.logger&&gbar.logger.ml(e,{"_sn":"cfg.init"});}})();
(function(){try{var b=window.gbar.i.i;var c=window.gbar;var f=function(d){try{var a=document.getElementById("gbom");a&&d.appendChild(a.cloneNode(!0))}catch(e){b(e,"omas","aomc")}};c.aomc=f;}catch(e){window.gbar&&gbar.logger&&gbar.logger.ml(e,{"_sn":"cfg.init"});}})();
(function(){try{var a=window.gbar;a.mcf("pm",{p:""});}catch(e){window.gbar&&gbar.logger&&gbar.logger.ml(e,{"_sn":"cfg.init"});}})();
(function(){try{window.gbar.rdl();}catch(e){window.gbar&&gbar.logger&&gbar.logger.ml(e,{"_sn":"cfg.init"});}})();
if (window['_OC_timingAction']) {window['_OC_timingAction']('patents_refpage');}</script><style>#gbar,#guser{font-size:13px;padding-top:1px !important;}#gbar{float:left;height:22px}#guser{padding-bottom:7px !important;text-align:right}.gbh,.gbd{border-top:1px solid #c9d7f1;font-size:1px}.gbh{height:0;position:absolute;top:24px;width:100%}#gbs,.gbm{background:#fff;left:0;position:absolute;text-align:left;visibility:hidden;z-index:1000}.gbm{border:1px solid;border-color:#c9d7f1 #36c #36c #a2bae7;z-index:1001}.gb1{margin-right:.5em}.gb1,.gb3{zoom:1}.gb2{display:block;padding:.2em .5em}.gb2,.gb3{text-decoration:none !important;border-bottom:none}a.gb1,a.gb4{text-decoration:underline !important}a.gb1,a.gb2,a.gb3,a.gb4{color:#00c !important}.gbi .gb3,.gbi .gb2,.gbi .gb4{color:#dd8e27 !important}.gbf .gb3,.gbf .gb2,.gbf .gb4{color:#900 !important}a.gb2:hover{background:#36c;color:#fff !important}#gbar .gbz0l{color:#000 !important;cursor:default;font-weight:bold;text-decoration:none !important}
#gbar { padding:.3em .6em !important;}</style></head><body  topmargin="3" marginheight="3"><div id=gbar><nobr><a onclick=gbar.qs(this);gbar.logger.il(1,{t:1}); class=gb1 id=gb_1 href="https://www.google.com/search?sa=N&tab=tw">Search</a> <a onclick=gbar.qs(this);gbar.logger.il(1,{t:2}); class=gb1 id=gb_2 href="http://www.google.com/search?hl=en&tbm=isch&source=og&sa=N&tab=ti">Images</a> <a onclick=gbar.qs(this);gbar.logger.il(1,{t:8}); class=gb1 id=gb_8 href="http://maps.google.com/maps?hl=en&sa=N&tab=tl">Maps</a> <a onclick=gbar.qs(this);gbar.logger.il(1,{t:78}); class=gb1 id=gb_78 href="https://play.google.com/?hl=en&sa=N&tab=t8">Play</a> <a onclick=gbar.qs(this);gbar.logger.il(1,{t:36}); class=gb1 id=gb_36 href="http://www.youtube.com/results?sa=N&tab=t1">YouTube</a> <a onclick=gbar.logger.il(1,{t:5}); class=gb1 id=gb_5 href="http://news.google.com/nwshp?hl=en&tab=tn">News</a> <a onclick=gbar.logger.il(1,{t:23}); class=gb1 id=gb_23 href="https://mail.google.com/mail/?tab=tm">Gmail</a> <a onclick=gbar.logger.il(1,{t:25}); class=gb1 id=gb_25 href="https://drive.google.com/?tab=to">Drive</a> <a class=gb3 href="http://www.google.com/intl/en/options/" onclick="this.blur();gbar.tg(event);return !1" aria-haspopup=true><u>More</u> <small>&#9660;</small></a><div class=gbm id=gbi><a onclick=gbar.logger.il(1,{t:24}); class=gb2 id=gb_24 href="https://www.google.com/calendar?tab=tc">Calendar</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:51}); class=gb2 id=gb_51 href="http://translate.google.com/?hl=en&sa=N&tab=tT">Translate</a><a onclick=gbar.logger.il(1,{t:17}); class=gb2 id=gb_17 href="http://www.google.com/mobile/?hl=en&tab=tD">Mobile</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:10}); class=gb2 id=gb_10 href="http://www.google.com/search?hl=en&tbo=u&tbm=bks&source=og&sa=N&tab=tp">Books</a><a onclick=gbar.logger.il(1,{t:212}); class=gb2 id=gb_212 href="https://wallet.google.com/manage/?tab=ta">Wallet</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:6}); class=gb2 id=gb_6 href="http://www.google.com/search?hl=en&tbo=u&tbm=shop&source=og&sa=N&tab=tf">Shopping</a><a onclick=gbar.logger.il(1,{t:30}); class=gb2 id=gb_30 href="http://www.blogger.com/?tab=tj">Blogger</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:27}); class=gb2 id=gb_27 href="http://www.google.com/finance?sa=N&tab=te">Finance</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:31}); class=gb2 id=gb_31 href="https://plus.google.com/photos?sa=N&tab=tq">Photos</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:12}); class=gb2 id=gb_12 href="http://www.google.com/search?hl=en&tbo=u&tbm=vid&source=og&sa=N&tab=tv">Videos</a><div class=gb2><div class=gbd></div></div><a onclick=gbar.logger.il(1,{t:66}); href="http://www.google.com/intl/en/options/" class=gb2>Even more &raquo;</a></div></nobr></div><div id=guser width=100%><nobr><span id=gbn class=gbi></span><span id=gbf class=gbf></span><span id=gbe></span><a target=_top id=gb_70 href="https://www.google.com/accounts/Login?service=&continue=http://www.google.com/patents%3Fhl%3Den&hl=en" class=gb4>Sign in</a><div style="display: none"><div class=gbm id=gbd5 aria-owner=gbg5><div class=gbmc><ol id=gbom class=gbmcc></ol></div></div></div></nobr></div><div class=gbh style=left:0></div><div class=gbh style=right:0></div><div role="alert" style="position: absolute; left: 0; right: 0;"><a href="http://www.google.com/patents/us6514520?hl=en&amp;output=html_text" title="Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader."><img border="0" src="http://www.google.com/images/cleardot.gif"alt="Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader."></a></div><div id="guser"><nobr></nobr></div><div style="clear:both;"></div><div id="gb-top-search-box" class="gb-top-search-box-small gb-reset"><table><tr><td class="logo"><a href="http://www.google.com/patents" class="logo-link"><img class="logo-img" src="/intl/en/images/logos/google_logo_41.png" alt="Go to Google Books Home" height="41"/></a></td><td><form action="http://www.google.com/search" name="f" id="vheadf" method="get"><span id="hf"></span><input type="hidden" name="tbm" value="pts"/><input type="hidden" name="tbo" value="1"/><input type="hidden" name="hl" value="en"/><table><tr><td><div class="inputs"><table><tr><td><div class="text-input"><input type="text" name="q" id="vheadq" class="text" maxlength="2048" size="31" value="" title="Search Patents" accesskey="s" autocomplete="off"/><script>window._OC_autoDir &&window._OC_autoDir('vheadq', 'tia-vheadq');</script></div></td><td><div class="submit-input"><input name="btnG" class="submit" type="submit" value=""/></div></td></tr></table></div></td><td class="col-ext-links"><div class="ext-links"><a href="http://www.google.com/advanced_patent_search">&lt;nobr&gt;Advanced Patent Search&lt;/nobr&gt;</a></div></td></tr></table></form></td></tr></table></div><div class="kd-appbar"><h2 class="kd-appname"><a href="/patents">Patents</a></h2><div class="kd-buttonbar left" id="left-toolbar-buttons"><a id="appbar-write-review-link" href=""></a><a id="appbar-view-print-sample-link" href=""></a><a id="appbar-view-ebook-sample-link" href=""></a><a id="appbar-patents-prior-art-finder-link" href="https://www.google.com/patents/related/US6514520"></a><a id="appbar-patents-discuss-this-link" href="http://www.google.com/url?id=kRReBAABERAJ&amp;q=http://patents.stackexchange.com/redirect/google-patents%3Fpatent%3DUS6514520&amp;usg=AFQjCNEL3jYRVoOR8hzIfIcGl3-o7BKv6g" data-is-grant="true"></a><a id="appbar-read-patent-link" href="//docs.google.com/viewer?url=patentimages.storage.googleapis.com/pdfs/US6514520.pdf"></a><a id="appbar-download-pdf-link" href="//patentimages.storage.googleapis.com/pdfs/US6514520.pdf"></a><a class="appbar-application-grant-link" data-label="Application" href="/patents/US20020132805"></a><a class="appbar-application-grant-link" data-selected="true" data-label="Grant" href="/patents/US6514520"></a></div><div class="kd-buttonbar right" id="right-toolbar-buttons"></div></div><div id="books-microdata" itemscope=""itemtype="http://schema.org/Book"itemid="http://www.google.com/patents/US6514520" style="display:none"><span itemprop="description">An antihistaminic syrup is stabilized against degradation of the active ingredient, by the addition of and about 0.05 to about 5 mg/mL of an aminopolycarboxylic acid such as a salt of ethylenediaminetetraacetic acid....</span><span itemprop="url">http://www.google.com/patents/US6514520?utm_source=gb-gplus-share</span><span class="main-title" itemprop="name">Patent US6514520 - Containing about 0.05 to about 5 mg/mL of an aminopolycarboxylic acid, including salts such as disodium EDTA; especially the antihistamines loratadine, descarboethoxyloratadine, and azatadine</span><img itemprop="image" src="http://www.google.com/patents?id=&amp;printsec=frontcover&amp;img=1&amp;zoom=1"alt="Patent US6514520 - Containing about 0.05 to about 5 mg/mL of an aminopolycarboxylic acid, including salts such as disodium EDTA; especially the antihistamines loratadine, descarboethoxyloratadine, and azatadine" title="Patent US6514520 - Containing about 0.05 to about 5 mg/mL of an aminopolycarboxylic acid, including salts such as disodium EDTA; especially the antihistamines loratadine, descarboethoxyloratadine, and azatadine"></div><div style="display: none"><ol id="ofe-gear-menu-contents" class="gbmcc"><li class="gbe gbmtc"><a class="gbmt goog-menuitem-content" id="" href="http://www.google.com/advanced_patent_search">Advanced Patent Search</a></li></ol></div><table id="viewport_table" cellpadding="0" style="clear:both" cellspacing="0"><tr><td id="viewport_td"><div class=vertical_module_list_row><div id=intl_patents class=about_content><div id=intl_patents_v><table class="patent-bibdata"><tr><td class="patent-bibdata-heading">Publication number</td><td class="single-patent-bibdata">US6514520 B2</td></tr><tr><td class="patent-bibdata-heading">Publication type</td><td class="single-patent-bibdata">Grant</td></tr><tr><td class="patent-bibdata-heading">Application number</td><td class="single-patent-bibdata">US 09/899,764</td></tr><tr><td class="patent-bibdata-heading">Publication date</td><td class="single-patent-bibdata">Feb 4, 2003</td></tr><tr><td class="patent-bibdata-heading">Filing date</td><td class="single-patent-bibdata">Jul 5, 2001</td></tr><tr><td class="patent-bibdata-heading">Priority date<span class="patent-tooltip-anchor patent-question-icon"data-tooltip-text="The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed."></span></td><td class="single-patent-bibdata">Jun 1, 1998</td></tr><tr><td class="patent-bibdata-heading">Fee status<span class="patent-tooltip-anchor patent-question-icon"data-tooltip-text="The fee status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status or dates listed."></span></td><td class="single-patent-bibdata">Paid</td></tr><tr class="patent-bibdata-list-row "><td class="patent-bibdata-heading">Also published as</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value"><a href="/patents/CA2333528A1">CA2333528A1</a>, </span><span class="patent-bibdata-value"><a href="/patents/CA2333528C">CA2333528C</a>, </span><span class="patent-bibdata-value"><a href="/patents/DE69914192D1">DE69914192D1</a>, </span><span class="patent-bibdata-value"><a href="/patents/DE69914192T2">DE69914192T2</a>, </span><span class="patent-bibdata-value"><a href="/patents/EP1082117A1">EP1082117A1</a>, </span><span class="patent-bibdata-value"><a href="/patents/EP1082117B1">EP1082117B1</a>, </span><span class="patent-bibdata-value"><a href="/patents/US6132758">US6132758</a>, </span><span class="patent-bibdata-value"><a href="/patents/US6939550">US6939550</a>, </span><span class="patent-bibdata-value"><a href="/patents/US20020132805">US20020132805</a>, </span><span class="patent-bibdata-value"><a href="/patents/US20030152595">US20030152595</a>, </span><span class="patent-bibdata-value"><a href="/patents/US20050261280">US20050261280</a>, </span><span class="patent-bibdata-value"><a href="/patents/WO1999062516A1">WO1999062516A1</a></span></span></td></tr><tr class="patent-bibdata-list-row alternate-patent-number"><td class="patent-bibdata-heading">Publication number</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value">09899764, </span><span class="patent-bibdata-value">899764, </span><span class="patent-bibdata-value">US 6514520 B2, </span><span class="patent-bibdata-value">US 6514520B2, </span><span class="patent-bibdata-value">US-B2-6514520, </span><span class="patent-bibdata-value">US6514520 B2, </span><span class="patent-bibdata-value">US6514520B2</span></span></td></tr><tr class="patent-bibdata-list-row "><td class="patent-bibdata-heading">Inventors</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value"><a href="http://www.google.com/search?tbo=p&tbm=pts&hl=en&q=ininventor:%22Farah+J.+Munayyer%22">Farah J. Munayyer</a>, </span><span class="patent-bibdata-value"><a href="http://www.google.com/search?tbo=p&tbm=pts&hl=en&q=ininventor:%22Frank+Guazzo%22">Frank Guazzo</a>, </span><span class="patent-bibdata-value"><a href="http://www.google.com/search?tbo=p&tbm=pts&hl=en&q=ininventor:%22Elliot+I.+Stupak%22">Elliot I. Stupak</a>, </span><span class="patent-bibdata-value"><a href="http://www.google.com/search?tbo=p&tbm=pts&hl=en&q=ininventor:%22Imtiaz+A.+Chaudry%22">Imtiaz A. Chaudry</a>, </span><span class="patent-bibdata-value"><a href="http://www.google.com/search?tbo=p&tbm=pts&hl=en&q=ininventor:%22Joel+A.+Sequeira%22">Joel A. Sequeira</a></span></span></td></tr><tr class="patent-bibdata-list-row "><td class="patent-bibdata-heading">Original Assignee</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value"><a href="http://www.google.com/search?tbo=p&tbm=pts&hl=en&q=inassignee:%22Schering+Corporation%22">Schering Corporation</a></span></span></td></tr><tr class="patent-bibdata-list-row "><td class="patent-bibdata-heading">Export Citation</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value"><a href="/patents/US6514520.bibtex">BiBTeX</a>, </span><span class="patent-bibdata-value"><a href="/patents/US6514520.enw">EndNote</a>, </span><span class="patent-bibdata-value"><a href="/patents/US6514520.ris">RefMan</a></span></span></td></tr><tr class="patent-internal-links"><td colspan=2><span class="patent-bibdata-value"><a href="#backward-citations">Patent Citations</a> (10),</span> <span class="patent-bibdata-value"><a href="#npl-citations">Non-Patent Citations</a> (3),</span> <span class="patent-bibdata-value"><a href="#forward-citations">Referenced by</a> (9),</span> <span class="patent-bibdata-value"><a href="#classifications">Classifications</a> (30),</span> <span class="patent-bibdata-value"><a href="#legal-events">Legal Events</a> (5)</span> </td></tr><tr><td colspan=2 class="patent-bibdata-external-link-spacer-top"></td></tr><tr class="patent-bibdata-external-link-spacer-bottom"></tr><tr><td colspan=2><span class="patent-bibdata-heading">External Links:&nbsp;</span><span><span class="patent-bibdata-value"><a href="http://www.google.com/url?id=kRReBAABERAJ&q=http://patft.uspto.gov/netacgi/nph-Parser%3FSect2%3DPTO1%26Sect2%3DHITOFF%26p%3D1%26u%3D/netahtml/PTO/search-bool.html%26r%3D1%26f%3DG%26l%3D50%26d%3DPALL%26RefSrch%3Dyes%26Query%3DPN/6514520&usg=AFQjCNHhEI2XHKysfysW9AiCue80E_H2Xw">USPTO</a>, </span><span class="patent-bibdata-value"><a href="http://www.google.com/url?id=kRReBAABERAJ&q=http://assignments.uspto.gov/assignments/q%3Fdb%3Dpat%26pat%3D6514520&usg=AFQjCNFVs_DXtjndDaZmpmez3BwdnEkuqQ">USPTO Assignment</a>, </span><span class="patent-bibdata-value"><a href="http://www.google.com/url?id=kRReBAABERAJ&q=http://worldwide.espacenet.com/publicationDetails/biblio%3FCC%3DUS%26NR%3D6514520B2%26KC%3DB2%26FT%3DD&usg=AFQjCNHvQmRYYeBur3K1GMgnAIxHa7UEhw">Espacenet</a></span></span></td></tr><tr class="patent-bibdata-group-spacer"></tr></table><div class="number-and-title"><span class="patent-title"><invention-title mxw-id="PT129124753" lang="EN" load-source="ifi">Containing about 0.05 to about 5 mg/mL of an aminopolycarboxylic acid, including salts such as disodium EDTA; especially the antihistamines loratadine, descarboethoxyloratadine, and azatadine</invention-title></span><br><span class="patent-number">US 6514520 B2</span></div><div class="patent-section patent-abstract-section"><div class="patent-section-header"><span class="patent-section-title">Abstract</span></div><div class="patent-text"><abstract mxw-id="PA50444213" lang="EN" load-source="patent-office"> <div class="abstract">An antihistaminic syrup is stabilized against degradation of the active ingredient, by the addition of and about 0.05 to about 5 mg/mL of an aminopolycarboxylic acid such as a salt of ethylenediaminetetraacetic acid.</div>
  </abstract></div></div><div class="patent-section patent-drawings-section"><div class="patent-section-header"><span class="patent-section-title">Images<span class="patent-section-count">(8)</span></span></div><div class="patent-drawings-body"><div class="patent-drawings-carousel"><div class="drawings"><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US6514520-0.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US6514520-0.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US6514520-1.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US6514520-1.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US6514520-2.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US6514520-2.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US6514520-3.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US6514520-3.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US6514520-4.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US6514520-4.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US6514520-5.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US6514520-5.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US6514520-6.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US6514520-6.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US6514520-7.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US6514520-7.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div></div></div><div class="patent-drawings-control patent-drawings-prev"><img class="patent-drawings-button-img" alt="Previous page"src="/googlebooks/images/kennedy/page_left.png"width="21" height="21" /></div><div class="patent-drawings-control patent-drawings-next"><img class="patent-drawings-button-img" alt="Next page"src="/googlebooks/images/kennedy/page_right.png"width="21" height="21" /></div></div></div><div class="patent-post-drawings"></div><div class="patent-section patent-claims-section"><div class="patent-section-header"><span class="patent-section-title">Claims<span class="patent-section-count">(20)</span></span></div><div class="patent-text"><div mxw-id="PCLM8429899" lang="EN" load-source="patent-office" class="claims">
    <claim-statement>What is claimed is: </claim-statement> <div class="claim"> <div num="1" id="US-6514520-B2-CLM-00001" class="claim">
      <div class="claim-text">1. An antihistaminic syrup formulation comprising descarboethoxyloratadine and about 0.05 to about 5 mg/mL of an aminopolycarboxylic acid or a salt thereof.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="2" id="US-6514520-B2-CLM-00002" class="claim">
      <div class="claim-text">2. The syrup of <claim-ref idref="US-6514520-B2-CLM-00001">claim 1</claim-ref>, wherein the aminopolycarboxylic acid is selected from the group consisting of: iminodiacetic acid; methyliminodiacetic acid; nitrilotriacetic acid; ethylenediaminetetraacetic acid; diethylenetriaminepentaacetic acid; 1,2-diaminocyclohexane-tetraacetic acid; N-hydroxyethylenediaminetriacetic acid; and any combination of two or more thereof.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="3" id="US-6514520-B2-CLM-00003" class="claim">
      <div class="claim-text">3. The syrup of <claim-ref idref="US-6514520-B2-CLM-00001">claim 1</claim-ref>, wherein the aminopolycarboxylic acid comprises ethylenediaminetetraacetic acid.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="4" id="US-6514520-B2-CLM-00004" class="claim">
      <div class="claim-text">4. The syrup of <claim-ref idref="US-6514520-B2-CLM-00001">claim 1</claim-ref>, in which the aminopolycarboxylic acid comprises about 0.1 to 1 mg/mL.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="5" id="US-6514520-B2-CLM-00005" class="claim">
      <div class="claim-text">5. The syrup of <claim-ref idref="US-6514520-B2-CLM-00003">claim 3</claim-ref>, in which the aminopolycarboxylic acid comprises about 0.25 to about 0.5 mg/mL.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="6" id="US-6514520-B2-CLM-00006" class="claim">
      <div class="claim-text">6. The syrup of <claim-ref idref="US-6514520-B2-CLM-00001">claim 1</claim-ref>, further containing a therapeutically effective amount of a decongestant, an analgesic, an antitussive, an expectorant, or any combination of two or more thereof.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="7" id="US-6514520-B2-CLM-00007" class="claim">
      <div class="claim-text">7. The syrup of <claim-ref idref="US-6514520-B2-CLM-00001">claim 1</claim-ref>, further containing a decongestant selected from the group consisting of pseudoephedrine and phenylpropanolamine.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="8" id="US-6514520-B2-CLM-00008" class="claim">
      <div class="claim-text">8. The syrup of <claim-ref idref="US-6514520-B2-CLM-00001">claim 1</claim-ref>, further containing the decongestant pseudoephedrine.</div>
    </div>
    </div> <div class="claim"> <div num="9" id="US-6514520-B2-CLM-00009" class="claim">
      <div class="claim-text">9. An antihistaminic syrup comprising descarboethoxyloratadine and an aminopolycarboxylic acid or a salt thereof.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="10" id="US-6514520-B2-CLM-00010" class="claim">
      <div class="claim-text">10. The antihistaminic syrup of <claim-ref idref="US-6514520-B2-CLM-00009">claim 9</claim-ref>, wherein the aminopolycarboxylic acid or salt is present in an amount sufficient to inhibit degradation of said descarboethoxyloratadine.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="11" id="US-6514520-B2-CLM-00011" class="claim">
      <div class="claim-text">11. The antihistaminic syrup of <claim-ref idref="US-6514520-B2-CLM-00009">claim 9</claim-ref>, wherein the aminopolycarboxylic acid is selected from the group consisting of: iminodiacetic acid; methyliminodiacetic acid; nitrilotriacetic acid; ethylenediaminetetraacetic acid; diethylenetriaminepentaacetic acid; 1,2-diaminocyclohexane-tetraacetic acid; N-hydroxyethylenediaminetriacetic acid; and a combination of two or more thereof.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="12" id="US-6514520-B2-CLM-00012" class="claim">
      <div class="claim-text">12. The antihistaminic syrup of <claim-ref idref="US-6514520-B2-CLM-00009">claim 9</claim-ref>, wherein the aminopolycarboxylic acid comprises ethylenediaminetetraacetic acid.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="13" id="US-6514520-B2-CLM-00013" class="claim">
      <div class="claim-text">13. The antihistaminic syrup of <claim-ref idref="US-6514520-B2-CLM-00012">claim 12</claim-ref>, wherein the ethylenediaminetetraacetic acid or salt is present in an amount sufficient to inhibit degradation of said descarboethoxyloratadine.</div>
    </div>
    </div> <div class="claim"> <div num="14" id="US-6514520-B2-CLM-00014" class="claim">
      <div class="claim-text">14. A syrup formulation comprising descarboethoxyloratadine and about 0.05 to about 5 mg/mL of an aminopolycarboxylic acid or a salt thereof, sufficient to inhibit degradation of said descarboethoxyloratadine.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="15" id="US-6514520-B2-CLM-00015" class="claim">
      <div class="claim-text">15. The syrup of <claim-ref idref="US-6514520-B2-CLM-00014">claim 14</claim-ref>, wherein the aminopolycarboxylic acid comprises ethylenediaminetetraacetic acid.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="16" id="US-6514520-B2-CLM-00016" class="claim">
      <div class="claim-text">16. The syrup of <claim-ref idref="US-6514520-B2-CLM-00015">claim 15</claim-ref>, wherein the ethylenediamine tetraacetic acid is present in an amount of about 0.25 to about 0.5 mg/mL.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="17" id="US-6514520-B2-CLM-00017" class="claim">
      <div class="claim-text">17. The syrup of <claim-ref idref="US-6514520-B2-CLM-00014">claim 14</claim-ref>, further comprising a therapeutically effective amount of a decongestant, analgesic, antitussive, expectorant or a combination of two or more thereof.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="18" id="US-6514520-B2-CLM-00018" class="claim">
      <div class="claim-text">18. The syrup of <claim-ref idref="US-6514520-B2-CLM-00014">claim 14</claim-ref>, further comprising pseudoephedrine or a salt thereof.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="19" id="US-6514520-B2-CLM-00019" class="claim">
      <div class="claim-text">19. The syrup of <claim-ref idref="US-6514520-B2-CLM-00018">claim 18</claim-ref>, further comprising an analgesic.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="20" id="US-6514520-B2-CLM-00020" class="claim">
      <div class="claim-text">20. The syrup of <claim-ref idref="US-6514520-B2-CLM-00014">claim 14</claim-ref>, further comprising a decongestant and an analgesic.</div>
    </div>
  </div> </div></div></div><div class="patent-section patent-description-section"><div class="patent-section-header"><span class="patent-section-title">Description</span></div><div class="patent-text"><div mxw-id="PDES53870686" lang="EN" load-source="patent-office" class="description">
    <heading>CROSS-REFERENCE TO RELATED APPLICATIONS</heading> <p>This application is a continuation of Ser. No. 09/708,188 filed Nov. 8, 2000 and now abandoned, which is a continuation of Ser. No. 09/616,866 filed Jul. 14, 2000 and now abandoned, which itself is a continuation of Ser. No. 09/088,128 filed Jun. 1, 1998 and now U.S. Pat. No. 6,132,758 granted Oct. 17, 2000.</p>
    <heading>INTRODUCTION TO THE INVENTION</heading> <p>The present invention pertains to the field of liquid pharmaceutical formulations, and more particularly to syrup formulations containing antihistamines.</p>
    <p>Syrup formulations are commonly used for delivery of pharmacological agents, particularly where the agents are to be delivered to pediatric patients. Traditional syrups are concentrated solutions of sugar (generally sucrose) in purified water, such as Syrup, NF prepared with 850 grams sucrose and sufficient water to make 1000 mL according to the procedure given in the official monograph at page 1990 of <i>NF XVII The National Formulary, </i>United States Pharmacopeial Convention, Inc., Rockville, Md. U.S.A., 1990. However, for purposes of the present invention, the term “syrup” will also encompass those liquid formulations having a sweet taste provided wholly or partly by artificial sweeteners, such as saccharin, sorbitol, aspartame, sodium cyclamate and the like, for avoidance of dental and medical problems which may be aggravated by higher caloric sweeteners. As is well appreciated in the art, syrups frequently are flavored, such as with fruit or mint flavors, usually for purposes of masking an unpleasant taste caused by the presence of a dissolved or suspended pharmacologically active substance. A pleasant taste is particularly important when the formulation is intended for ingestion by children. Typical flavoring agents which are commonly used in sweetened pharmaceuticals, foods, candies, beverages and the like are also useful in the present invention; these materials impart flavors such as grape, cherry, citrus, peach, strawberry, bubble gum, peppermint and many others.</p>
    <p>Syrups frequently must contain antimicrobial components to ensure safe storage without the proliferation of pathogenic molds, yeasts, bacteria and the like; a typical antimicrobial deemed suitable for use in foods and other ingestable substances is sodium benzoate. In addition, those syrups which do not contain sugar, or which contain a mixture of sugar and another sweetener, may contain thickening agents (such as a hydroxypropyl methylcellulose, some forms of which are available from Dow Chemical, Midland, Mich. USA under the METHOCEL trademark) to provide a viscous mouth-feel similar to that of a traditional syrup.</p>
    <p>An example of a currently marketed syrup contains 1 mg/mL of the antihistaminic drug loratadine, together with citric acid, artificial flavor, glycerin, propylene glycol, sodium benzoate, sucrose and water; this formulation typically has a pH value between about 2 and 4. However, under certain storage conditions involving contact with the air, losses of loratadine content, and a concomitant generation of impurities, have occurred. Similar problems can occur with formulations containing other, chemically related, drugs, such as descarboethoxyloratadine and azatadine.</p>
    <p>J. S. Nairn, “Solutions, Emulsions, Suspensions and Extracts,” Chapter 83 in A. R. Gennaro, Ed., <i>Remington's Pharmaceutical Sciences, </i>18th Ed., Mack Publishing Co., Easton Penn. U.S.A., 1990 at pages 1519-1520 discusses the problem of active agent stability in aqueous media. It is stated that trace metal-initiated oxidation reactions can be minimized through the use of citric acid or EDTA sequestering agents.</p>
    <p>It is desired to provide a storage-stable syrup formulation of loratadine or related antihistaminic components, which contains only components recognized as being safe for human ingestion.</p>
    <heading>SUMMARY OF THE INVENTION</heading> <p>In accordance with the invention, there is provided a syrup formulation containing loratadine or a chemically related antihistamine, including any pharmaceutically acceptable salt thereof, together with a stabilizing amount of an aminopolycarboxylic acid. Suitable aminopolycarboxylic acids include ethylenediaminetetraacetic acid (“EDTA”) and salts thereof, such as the disodium salt. The acid or salt is usually present in the formulation in concentrations about 0.05 mg/mL to about 5 mg/mL.</p>
    <heading>DETAILED DESCRIPTION OF THE INVENTION</heading> <p>Loratadine is the drug name given to the compound known as ethyl 4-(8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)-1-piperidinecarboxylate and having the empirical formula C<sub>22</sub>H<sub>23</sub>CIN<sub>2</sub>O<sub>2</sub>. A structure for this compound is: <chemistry> <div class="patent-image"> <a href="//patentimages.storage.googleapis.com/US6514520B2/US06514520-20030204-C00001.png"> <img id="EMI-C00001" file="US06514520-20030204-C00001.TIF" wi="111.84075" he="110.42325" img-content="chem" img-format="tif" alt="Figure US06514520-20030204-C00001" src="//patentimages.storage.googleapis.com/US6514520B2/US06514520-20030204-C00001.png" class="patent-full-image" width="447" height="441"> </a> </div> <attachments> <attachment idref="CHEMCDX-00001" attachment-type="cdx" file="US06514520-20030204-C00001.CDX"> </attachment> <attachment idref="CHEMMOL-00001" attachment-type="mol" file="US06514520-20030204-C00001.MOL"> </attachment> </attachments> </chemistry> </p>
    <p>The compound descarboethoxyloratadine is an antihistaminic active metabolite of loratadine, having the following structure: <chemistry> <div class="patent-image"> <a href="//patentimages.storage.googleapis.com/US6514520B2/US06514520-20030204-C00002.png"> <img id="EMI-C00002" file="US06514520-20030204-C00002.TIF" wi="111.84075" he="86.6376" img-content="chem" img-format="tif" alt="Figure US06514520-20030204-C00002" src="//patentimages.storage.googleapis.com/US6514520B2/US06514520-20030204-C00002.png" class="patent-full-image" width="447" height="346"> </a> </div> <attachments> <attachment idref="CHEMCDX-00002" attachment-type="cdx" file="US06514520-20030204-C00002.CDX"> </attachment> <attachment idref="CHEMMOL-00002" attachment-type="mol" file="US06514520-20030204-C00002.MOL"> </attachment> </attachments> </chemistry> </p>
    <p>A closely related antihistamine is azatadine, having the following structural formula: <chemistry> <div class="patent-image"> <a href="//patentimages.storage.googleapis.com/US6514520B2/US06514520-20030204-C00003.png"> <img id="EMI-C00003" file="US06514520-20030204-C00003.TIF" wi="91.6839" he="102.48525" img-content="chem" img-format="tif" alt="Figure US06514520-20030204-C00003" src="//patentimages.storage.googleapis.com/US6514520B2/US06514520-20030204-C00003.png" class="patent-full-image" width="366" height="409"> </a> </div> <attachments> <attachment idref="CHEMCDX-00003" attachment-type="cdx" file="US06514520-20030204-C00003.CDX"> </attachment> <attachment idref="CHEMMOL-00003" attachment-type="mol" file="US06514520-20030204-C00003.MOL"> </attachment> </attachments> </chemistry> </p>
    <p>Degradation of syrup formulations containing loratadine or related antihistamines is observed during storage stability testing, as evidenced by declining concentrations of the active ingredient and a concomitant formation of impurities. Two of the impurities which form in loratadine syrups have been identified as 2-Hydroxymethyl loratadine (“2-HML”) and 4-Hydroxymethyl loratadine (“4-HML”), while other unidentified impurities occur regularly and have been collectively denoted as “Group A”; these materials number about 5 to 7 and elute together in an HPLC analysis, at retention times which indicate a higher polarity than that of loratadine. The severity of the degradation may be at least approximately related to the volume in a product bottle which is not filled with syrup, i.e., the “headspace.” As it is not practical to fill each bottle completely to the top, a test has been conducted where the headspace was filled with nitrogen gas; results were inconclusive, possibly due to the unavoidable oxygen permeability of the polymeric bottle closure.</p>
    <p>Another test was conducted, wherein common antioxidant additives were incorporated into the syrup. Ideally, the antioxidant will be soluble in the syrup and is safe for use in foods and pharmaceutical preparations. Among the water-soluble materials, ascorbic acid at 0.1 and 1 mg/mL was found to somewhat reduce degradation, but also caused an unacceptable strong color change in the product, while sodium bisulfite imparted a pungent, disagreeable odor to the syrup. The oil-soluble antioxidants butylated hydroxytoluene and tocopherol were not soluble in the syrup, so also were not found acceptable.</p>
    <p>It has been found that the addition of small amounts of an aminopolycarboxylic acid, the term specifically including salts of the acids, can stabilize the syrups against degradation. Useful aminopolycarboxylic acids and salts thereof are those which are safe for ingestion and have sufficient solubility in the syrup formulations to make a stable single phase composition. Commercially available compounds which could be used include iminodiacetic acid, methyliminodiacetic acid, nitrilotriacetic acid, ethylenediaminetetraacetic acid (“EDTA”), diethylenetriaminepentaacetic acid, 1,2-diaminocyclohexane-tetraacetic acid, N-hydroxyethylenediaminetriacetic acid and related compounds. Mixtures of two or more of the foregoing are suitable for use. From the aspects of ready availability, safety, efficacy and cost, the alkali metal salts of EDTA are presently preferred, and the remainder of this description will focus on those materials.</p>
    <p>An aminopolycarboxylic acid or salt will typically be present in a syrup at about 0.05 mg/mL to about 5 mg/mL. More preferably, the level of aminopolycarboxylic acid will be about 0.1 mg/mL to about 1 mg/mL. As with any additive component in a formulation intended for ingestion, it is desirable to incorporate the minimum level which will yield the desired result. This level can be readily determined by means of an accelerated storage stability test, in which packages of the final product are stored at elevated temperatures above the usual storage temperatures to which the product is expected to be exposed; the present inventors have used temperatures up to 55° C. for this purpose, although such temperatures tend to cause a minor discoloration (darkening) of the syrups, probably due to some carmelization of the contained sucrose. It is expected that most drug degradation reactions will be accelerated by the elevated temperature. At predetermined intervals, some of the packages are opened and analyzed to determine the amount of active ingredients and impurities present in the formulation.</p>
    <p>Antihistaminic syrup formulations frequently also contain other drugs, for obtaining more than one therapeutic result from a single dose. Typical drug substances included with the antihistamine are sympathomimetic amine decongestants, such as pseudoephedrine or phenylpropanolamine (for relief of the upper airway congestion often accompanying disorders such as rhinitis and upper respiratory infections), and analgesics, such as aspirin, acetaminophen, ibuprofen, naproxen or ketoprofen (for relief of pain and, except in the case of acetaminophen, for reducing inflammation). Antitussives, such as codeine, hydrocodone or dextromethorphan, for relief from coughing, and expectorants such as guaifenesin, for increasing cough productivity, also are included in combination products. Any of these additional ingredients, including salts thereof and other drugs from the same therapeutic classes, are suitable for inclusion in the syrups of the present invention.</p>
    <p>The invention will be further described by means of the following examples, which are not intended to limit the scope of the invention as defined by the appended claims. Where the term “percent” is used herein, it is intended to represent percent by weight, unless the context clearly evidences otherwise.</p>
    <heading>EXAMPLE 1</heading> <p>A syrup was formulated to contain the following ingredients, wherein amounts of all except water are expressed in milligrams.</p>
    <p>
      <tables> <table frame="none" colsep="0" rowsep="0" class="description-table"> <tgroup align="left" colsep="0" rowsep="0" cols="3"> <colspec colname="offset" colwidth="35pt" align="left"> </colspec> <colspec colname="1" colwidth="70pt" align="left"> </colspec> <colspec colname="2" colwidth="112pt" align="center"> </colspec> <thead> <tr class="description-tr"> <td class="description-td"> </td>
                <td namest="OFFSET" nameend="2" align="center" rowsep="1" class="description-td" colspan="3"> </td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Ingredient</td>
                <td class="description-td">Amount</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td namest="OFFSET" nameend="2" align="center" rowsep="1" class="description-td" colspan="3"> </td>
              </tr> </thead> <tbody valign="top"> <tr class="description-tr"> <td class="description-td"> </td>
              </tr> </tbody> </tgroup> <tgroup align="left" colsep="0" rowsep="0" cols="3"> <colspec colname="offset" colwidth="35pt" align="left"> </colspec> <colspec colname="1" colwidth="70pt" align="left"> </colspec> <colspec colname="2" colwidth="112pt" align="char" char="."> </colspec> <tbody valign="top"> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Loratadine, micronized</td>
                <td class="description-td">1</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Citric acid</td>
                <td class="description-td">8.78</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Flavoring agent</td>
                <td class="description-td">2.5</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Glycerin</td>
                <td class="description-td">100</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Propylene glycol</td>
                <td class="description-td">100</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Sodium benzoate</td>
                <td class="description-td">1</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Disodium EDTA</td>
                <td class="description-td">0.25</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Sucrose</td>
                <td class="description-td">600</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Water</td>
                <td class="description-td">to make 1.0 mL</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td namest="OFFSET" nameend="2" align="center" rowsep="1" class="description-td" colspan="3"> </td>
              </tr> </tbody> </tgroup> </table> </tables> </p>
    <p>This syrup is prepared using the following procedure: (a) about 80 percent of the water is placed in a vessel, heated to 75-85° C., charged with the sugar and stirred to form a solution; (b) the citric acid is charged to the solution and stirring is continued to form a solution, then the sodium benzoate is added and dissolved; (c) the solution is cooled to 30-35° C., with continued stirring, and the disodium EDTA is added and dissolved; (d) the glycerin is added and stirring continued while the solution cools to 25-30° C.; (e) in a separate vessel, the propylene glycol and loratadine are combined and stirred to form a solution (note that the use of micronized loratadine particles decreases the time required to accomplish dissolution), then the flavoring agent is added and stirred to achieve homogeneity; (f) the product of step e is combined with the product of step d, with stirring to ensure homogeneity, and sufficient water is added to provide the proper formulation weight; and (g) the resulting syrup is passed through clarifying filters. The syrup is a clear, colorless liquid (which could readily be colored as desired, such as by adding a suitable pharmaceutically acceptable water-soluble dye to the sugar solution of step a) and is denoted Sample A.</p>
    <p>Another syrup is similarly formulated, except that it further contains 1 mg/mL of the disodium salt of EDTA. This is denoted Sample B.</p>
    <p>Twenty five mL portions of the two syrups are placed into 50 mL flint glass vials, then sealed with rubber stoppers and aluminum caps. The sealed vials are stored at 55° C. until their removal and analysis by high performance liquid chromatography. Results of the analyses are as follows, where “NQ” indicates a result below the limit of quantification (0.1%) but above the limit of detection (0.02%):</p>
    <p>
      <tables> <table frame="none" colsep="0" rowsep="0" class="description-table"> <tgroup align="left" colsep="0" rowsep="0" cols="3"> <colspec colname="1" colwidth="49pt" align="center"> </colspec> <colspec colname="2" colwidth="28pt" align="center"> </colspec> <colspec colname="3" colwidth="140pt" align="center"> </colspec> <tbody valign="top"> <tr class="description-tr"> <td namest="1" nameend="3" align="center" rowsep="1" class="description-td" colspan="3"> </td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Storage</td>
                <td class="description-td">Percent Degradation Products</td>
              </tr> </tbody> </tgroup> <tgroup align="left" colsep="0" rowsep="0" cols="5"> <colspec colname="1" colwidth="49pt" align="center"> </colspec> <colspec colname="2" colwidth="28pt" align="center"> </colspec> <colspec colname="3" colwidth="63pt" align="center"> </colspec> <colspec colname="4" colwidth="28pt" align="center"> </colspec> <colspec colname="5" colwidth="49pt" align="center"> </colspec> <tbody valign="top"> <tr class="description-tr"> <td class="description-td">Sample</td>
                <td class="description-td">(weeks)</td>
                <td class="description-td">2-HML</td>
                <td class="description-td">4-HML</td>
                <td class="description-td">Total</td>
              </tr> <tr class="description-tr"> <td namest="1" nameend="5" align="center" rowsep="1" class="description-td" colspan="5"> </td>
              </tr> </tbody> </tgroup> <tgroup align="left" colsep="0" rowsep="0" cols="5"> <colspec colname="1" colwidth="49pt" align="center"> </colspec> <colspec colname="2" colwidth="28pt" align="char" char="."> </colspec> <colspec colname="3" colwidth="63pt" align="center"> </colspec> <colspec colname="4" colwidth="28pt" align="char" char="."> </colspec> <colspec colname="5" colwidth="49pt" align="char" char="."> </colspec> <tbody valign="top"> <tr class="description-tr"> <td class="description-td">A</td>
                <td class="description-td">3</td>
                <td class="description-td">0.23</td>
                <td class="description-td">0.19</td>
                <td class="description-td">0.42</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">6</td>
                <td class="description-td">0.33</td>
                <td class="description-td">0.32</td>
                <td class="description-td">0.81<sup>a</sup> </td>
              </tr> <tr class="description-tr"> <td class="description-td">B</td>
                <td class="description-td">3</td>
                <td class="description-td">0.11</td>
                <td class="description-td">NQ</td>
                <td class="description-td">0.11</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">6</td>
                <td class="description-td">0.10</td>
                <td class="description-td">NQ</td>
                <td class="description-td">0.10</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">12</td>
                <td class="description-td">0.15</td>
                <td class="description-td">0.14</td>
                <td class="description-td">0.62<sup>b</sup> </td>
              </tr> <tr class="description-tr"> <td namest="1" nameend="5" align="center" rowsep="1" class="description-td" colspan="5"> </td>
              </tr> <tr class="description-tr"> <td namest="1" nameend="5" align="left" class="description-td" colspan="5"> <sup>a</sup>Sample contained 0.16% of an unidentified degradation product </td>
              </tr> <tr class="description-tr"> <td namest="1" nameend="5" align="left" class="description-td" colspan="5"> <sup>b</sup>Sample contained two unidentified degradation products at levels of 0.21% and 0.12% </td>
              </tr> </tbody> </tgroup> </table> </tables> </p>
    <p>These results indicate a significant inhibition by EDTA of the degradation of loratadine during the severe storage conditions of the test.</p>
    <heading>EXAMPLE 2</heading> <p>Sample A from the preceding example and similarly prepared syrups which also contain 0.1, 0.25, 0.5 or 0.75 mg/mL of disodium EDTA are packaged as in the prior example, and stored and tested similarly. The following results are obtained, where “ND” indicates a concentration below the limit of detection previously stated.</p>
    <p>
      <tables> <table frame="none" colsep="0" rowsep="0" class="description-table"> <tgroup align="left" colsep="0" rowsep="0" cols="3"> <colspec colname="1" colwidth="49pt" align="center"> </colspec> <colspec colname="2" colwidth="28pt" align="center"> </colspec> <colspec colname="3" colwidth="140pt" align="center"> </colspec> <tbody valign="top"> <tr class="description-tr"> <td namest="1" nameend="3" align="center" rowsep="1" class="description-td" colspan="3"> </td>
              </tr> <tr class="description-tr"> <td class="description-td">EDTA</td>
                <td class="description-td">Storage</td>
                <td class="description-td">Percent Degradation Products</td>
              </tr> </tbody> </tgroup> <tgroup align="left" colsep="0" rowsep="0" cols="5"> <colspec colname="1" colwidth="49pt" align="center"> </colspec> <colspec colname="2" colwidth="28pt" align="center"> </colspec> <colspec colname="3" colwidth="63pt" align="center"> </colspec> <colspec colname="4" colwidth="28pt" align="center"> </colspec> <colspec colname="5" colwidth="49pt" align="center"> </colspec> <tbody valign="top"> <tr class="description-tr"> <td class="description-td">(mg/mL)</td>
                <td class="description-td">(weeks)</td>
                <td class="description-td">2-HML</td>
                <td class="description-td">4-HML</td>
                <td class="description-td">Total</td>
              </tr> <tr class="description-tr"> <td namest="1" nameend="5" align="center" rowsep="1" class="description-td" colspan="5"> </td>
              </tr> </tbody> </tgroup> <tgroup align="left" colsep="0" rowsep="0" cols="5"> <colspec colname="1" colwidth="49pt" align="char" char="."> </colspec> <colspec colname="2" colwidth="28pt" align="char" char="."> </colspec> <colspec colname="3" colwidth="63pt" align="center"> </colspec> <colspec colname="4" colwidth="28pt" align="center"> </colspec> <colspec colname="5" colwidth="49pt" align="char" char="."> </colspec> <tbody valign="top"> <tr class="description-tr"> <td class="description-td">0</td>
                <td class="description-td">3</td>
                <td class="description-td">0.25</td>
                <td class="description-td">0.21</td>
                <td class="description-td">0.69<sup>a</sup> </td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">6</td>
                <td class="description-td">0.29</td>
                <td class="description-td">0.24</td>
                <td class="description-td">0.67<sup>b</sup> </td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">9</td>
                <td class="description-td">0.49</td>
                <td class="description-td">0.53</td>
                <td class="description-td">1.54<sup>c</sup> </td>
              </tr> <tr class="description-tr"> <td class="description-td">0.1</td>
                <td class="description-td">3</td>
                <td class="description-td">NQ</td>
                <td class="description-td">NQ</td>
                <td class="description-td">NQ</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">6</td>
                <td class="description-td">0.10</td>
                <td class="description-td">NQ</td>
                <td class="description-td">0.10</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">9</td>
                <td class="description-td">0.12</td>
                <td class="description-td">0.11</td>
                <td class="description-td">0.33<sup>d</sup> </td>
              </tr> <tr class="description-tr"> <td class="description-td">0.25</td>
                <td class="description-td">3</td>
                <td class="description-td">NQ</td>
                <td class="description-td">NQ</td>
                <td class="description-td">NQ</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">6</td>
                <td class="description-td">NQ</td>
                <td class="description-td">NQ</td>
                <td class="description-td">NQ</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">9</td>
                <td class="description-td">0.10</td>
                <td class="description-td">NQ</td>
                <td class="description-td">0.10</td>
              </tr> <tr class="description-tr"> <td class="description-td">0.5</td>
                <td class="description-td">3</td>
                <td class="description-td">NQ</td>
                <td class="description-td">ND</td>
                <td class="description-td">NQ</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">6</td>
                <td class="description-td">0.10</td>
                <td class="description-td">ND</td>
                <td class="description-td">0.10</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">9</td>
                <td class="description-td">0.11</td>
                <td class="description-td">0.10</td>
                <td class="description-td">0.21</td>
              </tr> <tr class="description-tr"> <td class="description-td">0.75</td>
                <td class="description-td">3</td>
                <td class="description-td">NQ</td>
                <td class="description-td">NQ</td>
                <td class="description-td">NQ</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">6</td>
                <td class="description-td">0.10</td>
                <td class="description-td">ND</td>
                <td class="description-td">0.10</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">9</td>
                <td class="description-td">0.10</td>
                <td class="description-td">0.10</td>
                <td class="description-td">0.20</td>
              </tr> <tr class="description-tr"> <td namest="1" nameend="5" align="center" rowsep="1" class="description-td" colspan="5"> </td>
              </tr> <tr class="description-tr"> <td namest="1" nameend="5" align="left" class="description-td" colspan="5"> <sup>a</sup>Sample contained 0.11% of Group A degradation products and 0.12% of an unidentified degradation product </td>
              </tr> <tr class="description-tr"> <td namest="1" nameend="5" align="left" class="description-td" colspan="5"> <sup>b</sup>Sample contained 0.14% of an unidentified degradation product </td>
              </tr> <tr class="description-tr"> <td namest="1" nameend="5" align="left" class="description-td" colspan="5"> <sup>c</sup>Sample contained three unidentified degradation products at levels of 0.17%, 0.13% and 0.22% </td>
              </tr> <tr class="description-tr"> <td namest="1" nameend="5" align="left" class="description-td" colspan="5"> <sup>d</sup>Sample contained 0.10% of an unidentified degradation product </td>
              </tr> </tbody> </tgroup> </table> </tables> </p>
    <p>These results suggest that 0.25 percent disodium EDTA would be a reasonable level for storage protection of the tested syrup.</p>
    <heading>EXAMPLE 3</heading> <p>A stabilized syrup is formulated according to the previously described general procedure to contain the following ingredients, wherein amounts of all except water are expressed in milligrams.</p>
    <p>
      <tables> <table frame="none" colsep="0" rowsep="0" class="description-table"> <tgroup align="left" colsep="0" rowsep="0" cols="3"> <colspec colname="offset" colwidth="28pt" align="left"> </colspec> <colspec colname="1" colwidth="77pt" align="left"> </colspec> <colspec colname="2" colwidth="112pt" align="center"> </colspec> <thead> <tr class="description-tr"> <td class="description-td"> </td>
                <td namest="OFFSET" nameend="2" align="center" rowsep="1" class="description-td" colspan="3"> </td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Ingredient</td>
                <td class="description-td">Amount</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td namest="OFFSET" nameend="2" align="center" rowsep="1" class="description-td" colspan="3"> </td>
              </tr> </thead> <tbody valign="top"> <tr class="description-tr"> <td class="description-td"> </td>
              </tr> </tbody> </tgroup> <tgroup align="left" colsep="0" rowsep="0" cols="3"> <colspec colname="offset" colwidth="28pt" align="left"> </colspec> <colspec colname="1" colwidth="77pt" align="left"> </colspec> <colspec colname="2" colwidth="112pt" align="char" char="."> </colspec> <tbody valign="top"> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Loratadine, Micronized</td>
                <td class="description-td">1</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Citric acid</td>
                <td class="description-td">8.78</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Flavoring agent</td>
                <td class="description-td">1.5</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Glycerin</td>
                <td class="description-td">100</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Propylene glycol</td>
                <td class="description-td">100</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Sodium benzoate</td>
                <td class="description-td">1</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Disodium EDTA</td>
                <td class="description-td">0.25</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Coloring agent</td>
                <td class="description-td">1</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Sucrose</td>
                <td class="description-td">400</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Water</td>
                <td class="description-td">to make 1.0 mL</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td namest="OFFSET" nameend="2" align="center" rowsep="1" class="description-td" colspan="3"> </td>
              </tr> </tbody> </tgroup> </table> </tables> </p>
    <p>This syrup is found to exhibit acceptable storage stability.</p>
    <heading>EXAMPLE 4</heading> <p>A stabilized syrup is formulated according to the previously described general procedure to contain the following ingredients, wherein amounts of all except water are expressed in milligrams.</p>
    <p>
      <tables> <table frame="none" colsep="0" rowsep="0" class="description-table"> <tgroup align="left" colsep="0" rowsep="0" cols="3"> <colspec colname="offset" colwidth="21pt" align="left"> </colspec> <colspec colname="1" colwidth="98pt" align="left"> </colspec> <colspec colname="2" colwidth="98pt" align="center"> </colspec> <thead> <tr class="description-tr"> <td class="description-td"> </td>
                <td namest="OFFSET" nameend="2" align="center" rowsep="1" class="description-td" colspan="3"> </td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Ingredient</td>
                <td class="description-td">Amount</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td namest="OFFSET" nameend="2" align="center" rowsep="1" class="description-td" colspan="3"> </td>
              </tr> </thead> <tbody valign="top"> <tr class="description-tr"> <td class="description-td"> </td>
              </tr> </tbody> </tgroup> <tgroup align="left" colsep="0" rowsep="0" cols="3"> <colspec colname="offset" colwidth="21pt" align="left"> </colspec> <colspec colname="1" colwidth="98pt" align="left"> </colspec> <colspec colname="2" colwidth="98pt" align="char" char="."> </colspec> <tbody valign="top"> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Loratadine, micronized</td>
                <td class="description-td">1</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Citric acid</td>
                <td class="description-td">0.48</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Sodium citrate</td>
                <td class="description-td">0.6</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Flavoring agent</td>
                <td class="description-td">1.5</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Glycerin</td>
                <td class="description-td">350</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Propylene glycol</td>
                <td class="description-td">100</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Sorbitol</td>
                <td class="description-td">150</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Sodium benzoate</td>
                <td class="description-td">1</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Disodium EDTA</td>
                <td class="description-td">0.25</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Sodium cyclamate</td>
                <td class="description-td">0.75</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Hydroxypropyl methylcellulose</td>
                <td class="description-td">0.5</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Coloring agent</td>
                <td class="description-td">1</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Water</td>
                <td class="description-td">to make 1.0 mL</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td namest="OFFSET" nameend="2" align="center" rowsep="1" class="description-td" colspan="3"> </td>
              </tr> </tbody> </tgroup> </table> </tables> </p>
    <p>This syrup is found to exhibit acceptable storage stability. METHOCEL™ K100M, K4M and A4M from Dow Chemical are among the hydroxypropyl methylcellulose products which are suitable for use in the invention; substituting the various available products can cause syrup viscosity changes, so experiments should be conducted to determine the appropriate grade and amount needed to prepare a given syrup with desired properties.</p>
    <heading>EXAMPLE 5</heading> <p>A stabilized syrup is formulated according to the previously described general procedure to contain the following ingredients, wherein amounts of all except water are expressed in milligrams.</p>
    <p>
      <tables> <table frame="none" colsep="0" rowsep="0" class="description-table"> <tgroup align="left" colsep="0" rowsep="0" cols="3"> <colspec colname="offset" colwidth="21pt" align="left"> </colspec> <colspec colname="1" colwidth="98pt" align="left"> </colspec> <colspec colname="2" colwidth="98pt" align="center"> </colspec> <thead> <tr class="description-tr"> <td class="description-td"> </td>
                <td namest="OFFSET" nameend="2" align="center" rowsep="1" class="description-td" colspan="3"> </td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Ingredient</td>
                <td class="description-td">Amount</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td namest="OFFSET" nameend="2" align="center" rowsep="1" class="description-td" colspan="3"> </td>
              </tr> </thead> <tbody valign="top"> <tr class="description-tr"> <td class="description-td"> </td>
              </tr> </tbody> </tgroup> <tgroup align="left" colsep="0" rowsep="0" cols="3"> <colspec colname="offset" colwidth="21pt" align="left"> </colspec> <colspec colname="1" colwidth="98pt" align="left"> </colspec> <colspec colname="2" colwidth="98pt" align="char" char="."> </colspec> <tbody valign="top"> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Loratadine, micronized</td>
                <td class="description-td">1</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Citric acid</td>
                <td class="description-td">0.48</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Sodium citrate</td>
                <td class="description-td">0.6</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Flavoring agent</td>
                <td class="description-td">1</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Glycerin</td>
                <td class="description-td">350</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Propylene glycol</td>
                <td class="description-td">100</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Sorbitol</td>
                <td class="description-td">150</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Sodium benzoate</td>
                <td class="description-td">1</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Disodium EDTA</td>
                <td class="description-td">0.25</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Saccharin</td>
                <td class="description-td">0.75</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Hydroxypropyl methylcellulose</td>
                <td class="description-td">0.5</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Water</td>
                <td class="description-td">to make 1.0 mL</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td namest="OFFSET" nameend="2" align="center" rowsep="1" class="description-td" colspan="3"> </td>
              </tr> </tbody> </tgroup> </table> </tables> </p>
    <p>This syrup is found to exhibit acceptable storage stability.</p>
    <heading>EXAMPLE 6</heading> <p>A stabilized syrup is formulated according to the previously described general procedure to contain the following ingredients, wherein amounts of all except water are expressed in milligrams.</p>
    <p>
      <tables> <table frame="none" colsep="0" rowsep="0" class="description-table"> <tgroup align="left" colsep="0" rowsep="0" cols="3"> <colspec colname="offset" colwidth="35pt" align="left"> </colspec> <colspec colname="1" colwidth="56pt" align="left"> </colspec> <colspec colname="2" colwidth="126pt" align="center"> </colspec> <thead> <tr class="description-tr"> <td class="description-td"> </td>
                <td namest="OFFSET" nameend="2" align="center" rowsep="1" class="description-td" colspan="3"> </td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Ingredient</td>
                <td class="description-td">Amount</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td namest="OFFSET" nameend="2" align="center" rowsep="1" class="description-td" colspan="3"> </td>
              </tr> </thead> <tbody valign="top"> <tr class="description-tr"> <td class="description-td"> </td>
              </tr> </tbody> </tgroup> <tgroup align="left" colsep="0" rowsep="0" cols="3"> <colspec colname="offset" colwidth="35pt" align="left"> </colspec> <colspec colname="1" colwidth="56pt" align="left"> </colspec> <colspec colname="2" colwidth="126pt" align="char" char="."> </colspec> <tbody valign="top"> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Loratadine</td>
                <td class="description-td">1</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Citric acid</td>
                <td class="description-td">0.48</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Sodium citrate</td>
                <td class="description-td">0.6</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Flavoring agent</td>
                <td class="description-td">2.5</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Glycerin</td>
                <td class="description-td">450</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Sorbitol</td>
                <td class="description-td">250</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Propylene glycol</td>
                <td class="description-td">100</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Sodium benzoate</td>
                <td class="description-td">1</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Disodium EDTA</td>
                <td class="description-td">0.25</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Water</td>
                <td class="description-td">to make 1.0 mL</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td namest="OFFSET" nameend="2" align="center" rowsep="1" class="description-td" colspan="3"> </td>
              </tr> </tbody> </tgroup> </table> </tables> </p>
    <p>This syrup is found to exhibit acceptable storage stability.</p>
    <heading>EXAMPLE 7</heading> <p>A stabilized syrup is formulated according to the previously described general procedure, but substituting descarboethoxyloratadine for loratadine, to contain the following ingredients, wherein amounts of all except water are expressed in milligrams.</p>
    <p>
      <tables> <table frame="none" colsep="0" rowsep="0" class="description-table"> <tgroup align="left" colsep="0" rowsep="0" cols="3"> <colspec colname="offset" colwidth="28pt" align="left"> </colspec> <colspec colname="1" colwidth="84pt" align="left"> </colspec> <colspec colname="2" colwidth="105pt" align="center"> </colspec> <thead> <tr class="description-tr"> <td class="description-td"> </td>
                <td namest="OFFSET" nameend="2" align="center" rowsep="1" class="description-td" colspan="3"> </td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Ingredient</td>
                <td class="description-td">Amount</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td namest="OFFSET" nameend="2" align="center" rowsep="1" class="description-td" colspan="3"> </td>
              </tr> </thead> <tbody valign="top"> <tr class="description-tr"> <td class="description-td"> </td>
              </tr> </tbody> </tgroup> <tgroup align="left" colsep="0" rowsep="0" cols="3"> <colspec colname="offset" colwidth="28pt" align="left"> </colspec> <colspec colname="1" colwidth="84pt" align="left"> </colspec> <colspec colname="2" colwidth="105pt" align="char" char="."> </colspec> <tbody valign="top"> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Descarboethoxyloratadine</td>
                <td class="description-td">1</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Citric acid</td>
                <td class="description-td">8.78</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Flavoring agent</td>
                <td class="description-td">2.5</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Glycerin</td>
                <td class="description-td">100</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Propylene glycol</td>
                <td class="description-td">100</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Sodium benzoate</td>
                <td class="description-td">1</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Disodium EDTA</td>
                <td class="description-td">0.25</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Sucrose</td>
                <td class="description-td">400</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Water</td>
                <td class="description-td">to make 1.0 mL</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td namest="OFFSET" nameend="2" align="center" rowsep="1" class="description-td" colspan="3"> </td>
              </tr> </tbody> </tgroup> </table> </tables> </p>
    <p>This syrup is found to exhibit acceptable storage stability.</p>
    <heading>EXAMPLE 8</heading> <p>A stabilized syrup is formulated according to the previously described general procedure, but substituting azatadine for loratadine, to contain the following ingredients, wherein amounts of all except water are expressed in milligrams.</p>
    <p>
      <tables> <table frame="none" colsep="0" rowsep="0" class="description-table"> <tgroup align="left" colsep="0" rowsep="0" cols="3"> <colspec colname="offset" colwidth="35pt" align="left"> </colspec> <colspec colname="1" colwidth="56pt" align="left"> </colspec> <colspec colname="2" colwidth="126pt" align="center"> </colspec> <thead> <tr class="description-tr"> <td class="description-td"> </td>
                <td namest="OFFSET" nameend="2" align="center" rowsep="1" class="description-td" colspan="3"> </td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Ingredient</td>
                <td class="description-td">Amount</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td namest="OFFSET" nameend="2" align="center" rowsep="1" class="description-td" colspan="3"> </td>
              </tr> </thead> <tbody valign="top"> <tr class="description-tr"> <td class="description-td"> </td>
              </tr> </tbody> </tgroup> <tgroup align="left" colsep="0" rowsep="0" cols="3"> <colspec colname="offset" colwidth="35pt" align="left"> </colspec> <colspec colname="1" colwidth="56pt" align="left"> </colspec> <colspec colname="2" colwidth="126pt" align="char" char="."> </colspec> <tbody valign="top"> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Azatadine</td>
                <td class="description-td">1</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Citric acid</td>
                <td class="description-td">8.78</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Flavoring agent</td>
                <td class="description-td">2.5</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Glycerin</td>
                <td class="description-td">100</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Propylene glycol</td>
                <td class="description-td">100</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Sodium benzoate</td>
                <td class="description-td">1</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Sucrose</td>
                <td class="description-td">600</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Water</td>
                <td class="description-td">to make 1.0 mL</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td namest="OFFSET" nameend="2" align="center" rowsep="1" class="description-td" colspan="3"> </td>
              </tr> </tbody> </tgroup> </table> </tables> </p>
    <p>This syrup is found to exhibit acceptable storage stability.</p>
    <heading>EXAMPLE 9</heading> <p>A stabilized syrup for pedriatric use is formulated according to the previously described general procedure to contain the following ingredients, wherein amounts of all except water are expressed in milligrams.</p>
    <p>
      <tables> <table frame="none" colsep="0" rowsep="0" class="description-table"> <tgroup align="left" colsep="0" rowsep="0" cols="3"> <colspec colname="offset" colwidth="28pt" align="left"> </colspec> <colspec colname="1" colwidth="105pt" align="left"> </colspec> <colspec colname="2" colwidth="84pt" align="center"> </colspec> <thead> <tr class="description-tr"> <td class="description-td"> </td>
                <td namest="OFFSET" nameend="2" align="center" rowsep="1" class="description-td" colspan="3"> </td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Ingredient</td>
                <td class="description-td">Amount</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td namest="OFFSET" nameend="2" align="center" rowsep="1" class="description-td" colspan="3"> </td>
              </tr> </thead> <tbody valign="top"> <tr class="description-tr"> <td class="description-td"> </td>
              </tr> </tbody> </tgroup> <tgroup align="left" colsep="0" rowsep="0" cols="3"> <colspec colname="offset" colwidth="28pt" align="left"> </colspec> <colspec colname="1" colwidth="105pt" align="left"> </colspec> <colspec colname="2" colwidth="84pt" align="char" char="."> </colspec> <tbody valign="top"> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Loratadine</td>
                <td class="description-td">0.5</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Pseudoephedrine sulfate</td>
                <td class="description-td">3</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Acetaminophen</td>
                <td class="description-td">32</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Dextromethorphan hydrobromide</td>
                <td class="description-td">1.5</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Citric acid</td>
                <td class="description-td">8.78</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Flavoring agent</td>
                <td class="description-td">1.5</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Glycerin</td>
                <td class="description-td">100</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Propylene glycol</td>
                <td class="description-td">100</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Sodium benzoate</td>
                <td class="description-td">1</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Disodium EDTA</td>
                <td class="description-td">0.25</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Coloring agent</td>
                <td class="description-td">1</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Sucrose</td>
                <td class="description-td">400</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Water</td>
                <td class="description-td">to make 1.0 mL</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td namest="OFFSET" nameend="2" align="center" rowsep="1" class="description-td" colspan="3"> </td>
              </tr> </tbody> </tgroup> </table> </tables> </p>
    <p>This syrup is found to exhibit acceptable storage stability.</p>
    </div></div></div><div class="patent-section patent-tabular-section"><a id="backward-citations"></a><div class="patent-section-header"><span class="patent-section-title">Patent Citations</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th class="patent-data-table-th">Cited Patent</th><th class="patent-data-table-th">Filing date</th><th class="patent-data-table-th">Publication date</th><th class="patent-data-table-th">Applicant</th><th class="patent-data-table-th">Title</th></tr></thead><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4659716">US4659716</a></td><td class="patent-data-table-td patent-date-value">Mar 12, 1986</td><td class="patent-data-table-td patent-date-value">Apr 21, 1987</td><td class="patent-data-table-td ">Schering Corporation</td><td class="patent-data-table-td ">Antihistaminic 8-(halo)-substituted 6,11-dihydro-11-(4-piperidylidene)-5H-benzo[5,6]cyclohepta[1,2-b]pyridines</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4783465">US4783465</a></td><td class="patent-data-table-td patent-date-value">Apr 24, 1987</td><td class="patent-data-table-td patent-date-value">Nov 8, 1988</td><td class="patent-data-table-td ">Analgesic Associates</td><td class="patent-data-table-td ">Cough/cold mixtures comprising non-sedating antihistamine drugs</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4975426">US4975426</a></td><td class="patent-data-table-td patent-date-value">Feb 24, 1989</td><td class="patent-data-table-td patent-date-value">Dec 4, 1990</td><td class="patent-data-table-td ">Analgesic Associates</td><td class="patent-data-table-td ">Cough/cold mixtures comprising non-sedating antihistamine drugs</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5759579">US5759579</a></td><td class="patent-data-table-td patent-date-value">Dec 5, 1996</td><td class="patent-data-table-td patent-date-value">Jun 2, 1998</td><td class="patent-data-table-td ">American Home Products Corporation</td><td class="patent-data-table-td ">Pharmaceutical suspension systems</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5912007">US5912007</a></td><td class="patent-data-table-td patent-date-value">Dec 6, 1996</td><td class="patent-data-table-td patent-date-value">Jun 15, 1999</td><td class="patent-data-table-td ">Warner-Lambert Company</td><td class="patent-data-table-td ">Delivery system for the localized administration of medicaments to the upper respiratory tract and methods for preparing and using same</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5939426">US5939426</a></td><td class="patent-data-table-td patent-date-value">Feb 28, 1997</td><td class="patent-data-table-td patent-date-value">Aug 17, 1999</td><td class="patent-data-table-td ">Sepracor Inc.</td><td class="patent-data-table-td ">Also for motion sickness and vertigo</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6132758">US6132758</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Jun 1, 1998</td><td class="patent-data-table-td patent-date-value">Oct 17, 2000</td><td class="patent-data-table-td ">Schering Corporation</td><td class="patent-data-table-td ">A loratadine and an aminopolycarboxylic acid or a salt thereof.</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP0620001A1?cl=en">EP0620001A1</a></td><td class="patent-data-table-td patent-date-value">Apr 15, 1994</td><td class="patent-data-table-td patent-date-value">Oct 19, 1994</td><td class="patent-data-table-td ">McNEIL-PPC, INC.</td><td class="patent-data-table-td ">Aqueous pharmaceutical suspension and process for preparation thereof</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO1998018470A1?cl=en">WO1998018470A1</a></td><td class="patent-data-table-td patent-date-value">Oct 29, 1997</td><td class="patent-data-table-td patent-date-value">May 7, 1998</td><td class="patent-data-table-td ">Schering Corp</td><td class="patent-data-table-td ">Composition, for the treatment of asthma, containing loratadine and a decongestant</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO1998024414A1?cl=en">WO1998024414A1</a></td><td class="patent-data-table-td patent-date-value">Dec 2, 1997</td><td class="patent-data-table-td patent-date-value">Jun 11, 1998</td><td class="patent-data-table-td ">American Home Prod</td><td class="patent-data-table-td ">Pharmaceutical suspension systems</td></tr></table><div class="patent-section-footer">* Cited by examiner</div></div><div class="patent-section patent-tabular-section"><a id="npl-citations"></a><div class="patent-section-header"><span class="patent-section-title">Non-Patent Citations</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th colspan="3"class="patent-data-table-th">Reference</th></tr></thead><tr><td class="patent-data-table-td ">1</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Drug Facts and Comparisons, 1998 Ed., Facts and Comparisons, St. Louis, Missouri, p. 2832.</td></tr><tr><td class="patent-data-table-td ">2</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Remington's Pharmaceutical Sciences, 18th Ed., Mack Publishing Company, Easton, Pennsylvania, 1990, pp. 1519-1520 and 1527-1529.</td></tr><tr><td class="patent-data-table-td ">3</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">The United States Pharmacopeia, The United States Formulary, United States Pharmacopeial Convention, Inc., Rockville, Maryland, 1989, p. 1990.</td></tr></table><div class="patent-section-footer"></div></div><div class="patent-section patent-tabular-section"><a id="forward-citations"></a><div class="patent-section-header"><span class="patent-section-title">Referenced by</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th class="patent-data-table-th">Citing Patent</th><th class="patent-data-table-th">Filing date</th><th class="patent-data-table-th">Publication date</th><th class="patent-data-table-th">Applicant</th><th class="patent-data-table-th">Title</th></tr></thead><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6709676">US6709676</a></td><td class="patent-data-table-td patent-date-value">Jun 19, 2002</td><td class="patent-data-table-td patent-date-value">Mar 23, 2004</td><td class="patent-data-table-td ">Schering Corporation</td><td class="patent-data-table-td ">Bilayer solid comprising an immediate release first layer of desloratadine, and an antioxidant or group 2a or aluminum salts and excipient, and a sustained release second layer of nasal decongestant such as pseudoephedrine sulfate</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6939550">US6939550</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Nov 15, 2002</td><td class="patent-data-table-td patent-date-value">Sep 6, 2005</td><td class="patent-data-table-td ">Schering Corporation</td><td class="patent-data-table-td ">Storage stability</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6979463">US6979463</a></td><td class="patent-data-table-td patent-date-value">Jun 19, 2002</td><td class="patent-data-table-td patent-date-value">Dec 27, 2005</td><td class="patent-data-table-td ">Schering Corporation</td><td class="patent-data-table-td ">Stable extended release oral dosage composition</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7405223">US7405223</a></td><td class="patent-data-table-td patent-date-value">Jan 16, 2001</td><td class="patent-data-table-td patent-date-value">Jul 29, 2008</td><td class="patent-data-table-td ">Schering Corporation</td><td class="patent-data-table-td ">Treating allergic and inflammatory conditions</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7618649">US7618649</a></td><td class="patent-data-table-td patent-date-value">Nov 3, 2003</td><td class="patent-data-table-td patent-date-value">Nov 17, 2009</td><td class="patent-data-table-td ">Schering Corporation</td><td class="patent-data-table-td ">For therapy of nasal and non-nasal symptoms of perennial and seasonal allergic rhinitis</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7820199">US7820199</a></td><td class="patent-data-table-td patent-date-value">Oct 6, 2005</td><td class="patent-data-table-td patent-date-value">Oct 26, 2010</td><td class="patent-data-table-td ">Schering Corporation</td><td class="patent-data-table-td ">for therapy of allergic and/or inflammatory conditions of the skin and airway passages; desloratadine-pseudoephedrine once-a-day product which produces a release rate profile for pseudoephedrine over an extended period in excess of twelve hours while maintaining delivery of desloratadine</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7902208">US7902208</a></td><td class="patent-data-table-td patent-date-value">May 30, 2008</td><td class="patent-data-table-td patent-date-value">Mar 8, 2011</td><td class="patent-data-table-td ">Schering Corporation</td><td class="patent-data-table-td ">Treating allergic and inflammatory conditions</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8187630">US8187630</a></td><td class="patent-data-table-td patent-date-value">Oct 2, 2009</td><td class="patent-data-table-td patent-date-value">May 29, 2012</td><td class="patent-data-table-td ">Schering-Plough Corporation</td><td class="patent-data-table-td ">Extended release oral dosage composition</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP1833461A1?cl=en">EP1833461A1</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by third party"> †</span></td><td class="patent-data-table-td patent-date-value">Dec 20, 2005</td><td class="patent-data-table-td patent-date-value">Sep 19, 2007</td><td class="patent-data-table-td ">Schering Corporation</td><td class="patent-data-table-td ">Pharmaceutical formulations</td></tr></table><div class="patent-section-footer">* Cited by examiner, † Cited by third party</div></div><div class="patent-section patent-tabular-section"><a id="classifications"></a><div class="patent-section-header"><span class="patent-section-title">Classifications</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th class="patent-data-table-th"> </th><th class="patent-data-table-th"> </th></tr></thead><tr><td class="patent-data-table-td ">U.S. Classification</td><td class="patent-data-table-td "><span class="nested-value"><a href="http://www.google.com/url?id=kRReBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc424/defs424.htm&usg=AFQjCNH9_TEmt6LWxUKihruum311Bzz0Rg#C424S439000">424/439</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=kRReBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc424/defs424.htm&usg=AFQjCNH9_TEmt6LWxUKihruum311Bzz0Rg#C424S400000">424/400</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=kRReBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc546/defs546.htm&usg=AFQjCNEVbqUa3Y2xdPcpKajVJNycCal0yg#C546S093000">546/93</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=kRReBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc514/defs514.htm&usg=AFQjCNG3QPK1Vhbpe6jO1mfvD3pMcfCuxA#C514S290000">514/290</a></span></td></tr><tr><td class="patent-data-table-td ">International Classification</td><td class="patent-data-table-td "><span class="nested-value"><a href="http://www.google.com/url?id=kRReBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61K0031445000">A61K31/445</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=kRReBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61K0009080000">A61K9/08</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=kRReBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61K0031198000">A61K31/198</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=kRReBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61K0031473000">A61K31/473</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=kRReBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61P0037080000">A61P37/08</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=kRReBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61P0043000000">A61P43/00</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=kRReBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61K0031550000">A61K31/55</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=kRReBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61K0009100000">A61K9/10</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=kRReBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61K0031454500">A61K31/4545</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=kRReBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61K0009000000">A61K9/00</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=kRReBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61K0047180000">A61K47/18</a></span></td></tr><tr><td class="patent-data-table-td ">Cooperative Classification</td><td class="patent-data-table-td "><span class="nested-value"><a href="http://www.google.com/url?id=kRReBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=Y10S514/849">Y10S514/849</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=kRReBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61K31/55">A61K31/55</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=kRReBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61K31/198">A61K31/198</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=kRReBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61K31/4545">A61K31/4545</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=kRReBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61K31/473">A61K31/473</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=kRReBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61K31/445">A61K31/445</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=kRReBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61K47/183">A61K47/183</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=kRReBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61K9/0095">A61K9/0095</a></span></td></tr><tr><td class="patent-data-table-td ">European Classification</td><td class="patent-data-table-td "><span class="nested-value">A61K31/445</span>, <span class="nested-value">A61K31/55</span>, <span class="nested-value">A61K31/198</span>, <span class="nested-value">A61K31/473</span>, <span class="nested-value">A61K31/4545</span>, <span class="nested-value">A61K47/18B</span>, <span class="nested-value">A61K9/00Z6</span></td></tr></table><div class="patent-section-footer"></div></div><div class="patent-section patent-tabular-section"><a id="legal-events"></a><div class="patent-section-header"><span class="patent-section-title">Legal Events</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th class="patent-data-table-th">Date</th><th class="patent-data-table-th">Code</th><th class="patent-data-table-th">Event</th><th class="patent-data-table-th">Description</th></tr></thead><tr><td class="patent-data-table-td patent-date-value">Aug 30, 2012</td><td class="patent-data-table-td ">AS</td><td class="patent-data-table-td ">Assignment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Owner name: </span><span class="nested-value">MERCK SHARP &amp; DOHME CORP., NEW JERSEY</span></div><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">CHANGE OF NAME;ASSIGNOR:SCHERING CORPORATION;REEL/FRAME:028884/0151</span></div><div class="nested-key-value"><span class="nested-key">Effective date: </span><span class="nested-value">20120502</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Jul 2, 2010</td><td class="patent-data-table-td ">FPAY</td><td class="patent-data-table-td ">Fee payment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Year of fee payment: </span><span class="nested-value">8</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Oct 3, 2006</td><td class="patent-data-table-td ">B1</td><td class="patent-data-table-td ">Reexamination certificate first reexamination</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">THE PATENTABILITY OF CLAIMS 1-20 IS CONFIRMED.</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Jun 22, 2006</td><td class="patent-data-table-td ">FPAY</td><td class="patent-data-table-td ">Fee payment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Year of fee payment: </span><span class="nested-value">4</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Dec 9, 2003</td><td class="patent-data-table-td ">RR</td><td class="patent-data-table-td ">Request for reexamination filed</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Effective date: </span><span class="nested-value">20031022</span></div></td></tr></table><div class="patent-section-footer"></div></div><div class="modal-dialog" id="patent-images-lightbox"><div class="patent-lightbox-controls"><div class="patent-lightbox-rotate-controls"><div class="patent-lightbox-rotation-text">Rotate</div><div class="rotate-icon rotate-ccw-icon"></div><div class="rotate-icon rotate-cw-icon"></div></div><div class="patent-lightbox-index-counter"></div><a class="patent-lightbox-fullsize-link" target="_blank">Original Image</a><div class="patent-drawings-control patent-drawings-next"><img class="patent-drawings-button-img"src="/googlebooks/images/kennedy/page_right.png" alt="Next page"width="21" height="21" /></div><div class="patent-drawings-control patent-drawings-prev"><img class="patent-drawings-button-img"src="/googlebooks/images/kennedy/page_left.png" alt="Previous page"width="21" height="21" /></div></div><div class="modal-dialog-content"><div class="patent-lightbox-image-holder"><div class="patent-lightbox-placeholder"></div></div></div></div><script>_OC_initPatentsAtb({image_not_available_html: " Image not available"});</script></div></div></div></td></tr></table><script>(function() {var href = window.location.href;if (href.indexOf('?') !== -1) {var parameters = href.split('?')[1].split('&');for (var i = 0; i < parameters.length; i++) {var param = parameters[i].split('=');if (param[0] == 'focus') {var elem = document.getElementById(param[1]);if (elem) {elem.focus();}}}}})();</script><script>_OC_addFlags({LockSrc:"/books/javascript/lock_8a2b04e7bf975d5171d8e4c0b6365c7a.js", Host:"http://www.google.com/", IsBooksRentalEnabled:1, IsWebstoreDisplayCaseEnabled:1, IsObfuscationEnabled:1, IsBrowsingHistoryEnabled:1, IsWebReaderSvgEnabled:0, IsGeoLayerEnabled:1, IsImageModeNotesEnabled:1, IsCopyMenuItemEnabled:1, IsGiftingEnabled:0, IsWebReaderUniversalPaginatorEnabled:0, IsOfflineBubbleEnabled:1, IsReaderEnabledForPlayRequests:1, IsFutureOnSaleVolumesEnabled:1, IsOfflineRestrictedCopyEnabled:1, IsBooksUnifiedLeftNavEnabled:1, IsRestrictedCopyEnabled:1, IsZipitFolderCollectionEnabled:1, IsEndOfSampleRecommendationsEnabled:1, IsRatingsOnBookcardsEnabled:1, IsAdsDisabled:0, IsIframePageDisplayEnabled:0, IsEmbeddedMediaEnabled:1, IsImageModeAnnotationsEnabled:1, IsMyLibraryGooglePlusEnabled:1, IsImagePageProviderEnabled:0, IsBookcardListPriceSmall:0, IsInternalUser:0, IsBooksShareButtonEnabled:0, IsPreOrdersEnabled:0, IsDisabledRandomBookshelves:0, WebstoreDisplayCasePosition:3});_OC_Run({"enable_p13n":false,"add_vol_to_collection_base_url":"http://www.google.com/patents?op=add\u0026sig=ACfU3U3TvXeRv5cYPI5NxWmJ1xpPmhyMTA\u0026id=kRReBAABERAJ","remove_vol_from_collection_base_url":"http://www.google.com/patents?op=remove\u0026sig=ACfU3U3T7wugdapWLjbEB48dqGWM60-M7A\u0026id=kRReBAABERAJ","logged_in":false,"p13n_save_user_settings_url":"http://www.google.com/patents?op=edit_user_settings\u0026sig=ACfU3U0lXdSl_W6mTuQmLiqRc52EqfJabQ","is_cobrand":false,"sign_in_url":"https://www.google.com/accounts/Login?service=\u0026continue=http://www.google.com/patents%3Fhl%3Den\u0026hl=en","is_play_enabled":true}, {"volume_id":"","is_ebook":true,"volumeresult":{"has_flowing_text":false,"has_scanned_text":true,"can_download_pdf":false,"can_download_epub":false,"is_pdf_drm_enabled":false,"is_epub_drm_enabled":false,"download_pdf_url":"http://www.google.com/patents/download/Containing_about_0_05_to_about_5_mg_mL_o.pdf?id=kRReBAABERAJ\u0026output=pdf\u0026sig=ACfU3U3G5Profj9J0qJdOs12CGuVzK9VFg"},"sample_url":"http://www.google.com/patents/reader?id=kRReBAABERAJ\u0026printsec=frontcover\u0026output=reader\u0026source=gbs_atb_hover","is_browsable":true,"is_public_domain":true}, {});</script><div id="footer_table" style="font-size:83%;text-align:center;position:relative;top:20px;height:4.5em;margin-top:2em"><div style="margin-bottom:8px"><a href=http://www.google.com/><nobr>Google&nbsp;Home</nobr></a> - <a href=//www.google.com/patents/sitemap/><nobr>Sitemap</nobr></a> - <a href=http://www.google.com/googlebooks/uspto.html><nobr>USPTO Bulk Downloads</nobr></a> - <a href=/intl/en/privacy/><nobr>Privacy Policy</nobr></a> - <a href=/intl/en/policies/terms/><nobr>Terms of Service</nobr></a> - <a href=https://support.google.com/faqs/answer/2539193?hl=en><nobr>About Google Patents</nobr></a> - <a href="http://www.google.com/tools/feedback/intl/en/error.html" onclick="try{_OC_startFeedback({productId: '72792',locale: 'en'});return false;}catch(e){}"><nobr>Send Feedback</nobr></a></div><span>Data provided by IFI CLAIMS Patent Services</span><br><span >&copy;2012 Google</span></div> <script type="text/javascript">var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www.");document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E"));</script><script type="text/javascript">var pageTracker = _gat._getTracker("UA-27188110-1");pageTracker._setCookiePath("/patents/");pageTracker._trackPageview();</script> </body></html>